ANJIN GROUP, INC.

Basic Information

10 CHILHOWIE CT.
COCKEYSVILLE, MD, 21030 2202

Company Profile

n/a

Additional Details

Field Value
DUNS: 143606742
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Generation of a Modified DT_IL3 Fusion Toxin

    Amount: $122,830.00

    DESCRIPTION (provided by applicant): A number of protein fusion toxins, composed of the diphtheria toxin (DT) toxophore and a targeting ligand, have been assembled and tested in Phase I clinical trial ...

    SBIR Phase I 2008 Department of Health and Human Services
  2. Further Analysis of a VLS Modified IL-2 Receptor Targeted Toxin

    Amount: $147,459.00

    DESCRIPTION (provided by applicant): The project seeks to further the development of a series of diphtheria toxin mutants which, when employed in the construction of protein fusion toxins, display red ...

    SBIR Phase I 2008 Department of Health and Human Services
  3. Modified Diphtheria Toxin IL-7 Fusion Toxins

    Amount: $152,141.00

    DESCRIPTION (provided by applicant): Sweeney et al. (1998) originally reported the construction of DAB389IL-7, a fusion protein based on diphtheria toxin (DT), and proposed that this fusion protein co ...

    SBIR Phase I 2006 Department of Health and Human Services
  4. An IL-2 Receptor Targeted Toxin with Reduced VLS

    Amount: $144,786.00

    DESCRIPTION (provided by applicant): Well over a decade ago the first diphtheria toxin-based fusion protein toxin, DAB389IL-2 (Ontak(R)) was in development as the first of a new class of receptor spe ...

    SBIR Phase I 2005 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government